Abstract
Background Virtual care for patients with COVID-19 allows providers to monitor COVID-19 positive patients with variable trajectories while reducing the risk of transmission to others and managing healthcare capacity in acute care facilities.
Objective To develop and test the feasibility of a family medicine-led remote monitoring model of care (COVIDCare@Home program) to manage patients with COVID-19 in the community.
Methods This multi-faceted, family medicine-led, interprofessional team-based remote monitoring program was developed at Women’s College Hospital in Toronto, Ontario. A cross-sectional chart review of the first cohort of patients was conducted and learnings from the implementation of CovidCare@Home are described.
Results During the study period, April 8 to May 11, 2020, there were 97 patients (average age 48.6, 62% female) with 424 recorded virtual visits with a median virtual length of stay of 8 days (IQR 5). 5.2% required escalation to an in-person visit with no patients requiring hospitalization. 16% of patients required support with mental and social health needs.
Interpretations A family medicine-led, team-based remote monitoring program can safely be used to manage outpatients diagnosed with COVID-19. Attention to mental and social health needs is critical for this population. Future efforts should consider how to design programs to best support populations disproportionately impacted by COVID-19, something which primary care is well-positioned to do. Further analysis will describe the effectiveness, impact, and satisfaction with the program among patients and providers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no direct funding provided for this study. PA is funded in part by a New Investigator Award from the Department and Community Medicine at the University of Toronto. CL is funded by the Canadian Institute for Health Research, Health System Impact Fellowship (postdoctoral).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the local research ethics board at Womens College Hospital (2020-0058-E).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Portions of the data are available upon request to the corresponding author.
